Literature DB >> 10917548

Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.

H P Ciolino1, T T Wang, N Sathyamoorthy.   

Abstract

The effect of the chemopreventive synthetic retinoid N-(4-hydroxyphenyl)-retinamide (4-HPR) on aromatase activity and expression was examined. 4-HPR caused a dose-dependent inhibition of aromatase activity in microsomes isolated from JEG-3 human placental carcinoma cells. The kinetics of inhibition were analysed by double-reciprocal plot. The Km of the substrate increased and the Vmax of the reaction decreased in the presence of 4-HPR, indicating that enzyme inhibition involved both competition for the substrate-binding site and non-competitive mechanisms. To determine whether 4-HPR would also inhibit aromatase activity in intact cells, MCF-7 human breast cancer cells were incubated with or without cAMP in the presence of 4-HPR. 4-HPR inhibited both basal and cAMP-induced aromatase activity in intact MCF-7 cells. The induction of aromatase mRNA expression in MCF-7 cells by cAMP was inhibited in cells treated with 4-HPR. These results indicate that 4-HPR inhibits both the enzymatic activity and expression of aromatase. These activities may play an important role in the known chemopreventive effect of 4-HPR towards breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917548      PMCID: PMC2374555          DOI: 10.1054/bjoc.2000.1269

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

Review 1.  Estrogen regulation of cell cycle progression in breast cancer cells.

Authors:  O W Prall; E M Rogan; R L Sutherland
Journal:  J Steroid Biochem Mol Biol       Date:  1998-04       Impact factor: 4.292

2.  Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis.

Authors:  K A Crist; Y Wang; R A Lubet; V E Steele; G J Kelloff; M You
Journal:  J Cell Biochem Suppl       Date:  1997

Review 3.  Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis.

Authors:  R C Moon; A I Constantinou
Journal:  Breast Cancer Res Treat       Date:  1997 Nov-Dec       Impact factor: 4.872

Review 4.  Intratumoral aromatase in human breast, endometrial, and ovarian malignancies.

Authors:  H Sasano; N Harada
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

5.  Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cell cultures.

Authors:  R W Brueggemeier; N E Katlic
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

6.  Characterization of steroid production in cultured human choriocarcinoma cells.

Authors:  R S Bahn; A Worsham; K V Speeg; M Ascoli; D Rabin
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

7.  Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells.

Authors:  C Marth; G Böck; G Daxenbichler
Journal:  J Natl Cancer Inst       Date:  1985-11       Impact factor: 13.506

8.  Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.

Authors:  F Formelli; R Carsana; A Costa; F Buranelli; T Campa; G Dossena; A Magni; M Pizzichetta
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

9.  Oestradiol synthesis from C19 steroids by human breast cancers.

Authors:  W R Miller; A P Forrest
Journal:  Br J Cancer       Date:  1976-01       Impact factor: 7.640

10.  Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

Authors:  R E Favoni; A de Cupis; S Bruno; D Yee; A Ferrera; P Pirani; A Costa; A Decensi
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  5 in total

1.  Fenretinide: A Potential Treatment for Endometriosis.

Authors:  Mary Ellen Pavone; Saurabh S Malpani; Matthew Dyson; J Julie Kim; Serdar E Bulun
Journal:  Reprod Sci       Date:  2016-02-25       Impact factor: 3.060

Review 2.  Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.

Authors:  M Widschwendter; J Berger; H M Müller; A G Zeimet; C Marth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

3.  Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes.

Authors:  J T Sanderson; R J Letcher; M Heneweer; J P Giesy; M van den Berg
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

4.  Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

Authors:  Andrea Decensi; Chris Robertson; Aliana Guerrieri-Gonzaga; Davide Serrano; Massimiliano Cazzaniga; Serena Mora; Marcella Gulisano; Harriet Johansson; Viviana Galimberti; Enrico Cassano; Simona M Moroni; Franca Formelli; Ernst A Lien; Giuseppe Pelosi; Karen A Johnson; Bernardo Bonanni
Journal:  J Clin Oncol       Date:  2009-07-13       Impact factor: 44.544

5.  Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cells.

Authors:  Jiahui Zhang; Yifan Tu; Sallie Smith-Schneider
Journal:  Cancer Cell Int       Date:  2005-03-08       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.